Wealth Enhancement Advisory Services
CORT icon

Wealth Enhancement Advisory Services’s Corcept Therapeutics CORT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.65M Buy
+76,278
New +$4.61M 0.01% 854
2026
Q1 		– Sell
-21,552
Closed -$771K – 3636
2025
Q4 		$771K Buy
21,552
+803
+4% +$63.1K ﹤0.01% 2134
2025
Q3 		$1.87M Buy
20,749
+7,102
+52% +$514K ﹤0.01% 1479
2025
Q2 		$986K Buy
13,647
+5,693
+72% +$413K ﹤0.01% 1765
2025
Q1 		$909K Buy
7,954
+230
+3% +$14K ﹤0.01% 1648
2024
Q4 		$389K Buy
7,724
+2,578
+50% +$135K ﹤0.01% 2175
2024
Q3 		$238K Buy
+5,146
New +$183K ﹤0.01% 2336

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Enhancement Advisory Services's CORT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 76,278 shares worth $6.65M. The stake represents 0.01% of the portfolio and ranks #854 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in CORT as recently as Q4 2025.

Wealth Enhancement Advisory Services first reported a position in CORT in Q3 2024 and has held it in 7 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 76,278 shares of Corcept Therapeutics worth $6.65M as of Q2 2026.
  • Corcept Therapeutics was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Corcept Therapeutics made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #854 holding.
  • Wealth Enhancement Advisory Services first reported a position in Corcept Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.